Analysts: Ligand Pharmaceuticals Inc (LGND.OQ)
LGND.OQ on NASDAQ Stock Exchange Global Market
49.02USD
1 Aug 2013
49.02USD
1 Aug 2013
Price Change (% chg)
$1.64 (+3.46%)
$1.64 (+3.46%)
Prev Close
$47.38
$47.38
Open
$48.04
$48.04
Day's High
$50.39
$50.39
Day's Low
$46.85
$46.85
Volume
62,857
62,857
Avg. Vol
77,473
77,473
52-wk High
$50.77
$50.77
52-wk Low
$14.77
$14.77
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.09 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 3 | 3 | 2 | 2 |
| (3) HOLD | 1 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.71 | 1.71 | 1.67 | 1.67 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 5 | 10.43 | 11.78 | 9.30 | 12.07 |
| Quarter Ending Dec-13 | 5 | 14.17 | 14.90 | 13.04 | 13.35 |
| Year Ending Dec-13 | 5 | 45.58 | 46.80 | 44.30 | 45.51 |
| Year Ending Dec-14 | 6 | 61.53 | 64.00 | 57.60 | 65.57 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 4 | 0.09 | 0.11 | 0.07 | 0.14 |
| Quarter Ending Dec-13 | 5 | 0.24 | 0.28 | 0.21 | 0.18 |
| Year Ending Dec-13 | 3 | 0.54 | 0.59 | 0.51 | 0.47 |
| Year Ending Dec-14 | 6 | 1.05 | 1.30 | 0.74 | 0.90 |
| LT Growth Rate (%) | 1 | 30.00 | 30.00 | 30.00 | -- |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 10.00 | 11.65 | 1.65 | 16.50 |
| Quarter Ending Dec-12 | 13.27 | 13.64 | 0.36 | 2.75 |
| Quarter Ending Sep-12 | 6.09 | 6.38 | 0.29 | 4.71 |
| Quarter Ending Jun-12 | 7.12 | 5.74 | 1.38 | 19.41 |
| Quarter Ending Mar-12 | 8.02 | 5.64 | 2.38 | 29.72 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 0.09 | 0.16 | 0.07 | 86.05 |
| Quarter Ending Dec-12 | 0.21 | 0.19 | 0.02 | 8.65 |
| Quarter Ending Sep-12 | -0.04 | -0.01 | 0.03 | -76.19 |
| Quarter Ending Jun-12 | -0.03 | -0.20 | 0.17 | -700.00 |
| Quarter Ending Mar-12 | -0.02 | -0.03 | 0.01 | -79.64 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 10.43 | 10.43 | 10.47 | 10.58 | 12.07 |
| Quarter Ending Dec-13 | 14.17 | 14.17 | 14.81 | 14.89 | 13.35 |
| Year Ending Dec-13 | 45.58 | 45.58 | 46.24 | 46.31 | 45.51 |
| Year Ending Dec-14 | 61.53 | 61.53 | 62.36 | 61.69 | 65.57 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 0.09 | 0.09 | 0.09 | 0.10 | 0.14 |
| Quarter Ending Dec-13 | 0.24 | 0.24 | 0.28 | 0.29 | 0.18 |
| Quarter Ending Dec-13 | 0.54 | 0.54 | 0.58 | 0.63 | 0.47 |
| Quarter Ending Dec-14 | 1.05 | 1.05 | 1.08 | 0.94 | 0.90 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 1 |
| Year Ending Dec-13 | 0 | 0 | 1 | 1 |
| Year Ending Dec-14 | 0 | 0 | 1 | 1 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 1 | 0 | 2 |
| Year Ending Dec-14 | 0 | 0 | 0 | 1 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates